facebook-page-view
Advertisement

Novartis

KKR-controlled JB Chemicals inks deal to buy eyecare brands from Novartis

Healthcare

20 December, 2023

KKR-controlled JB Chemicals inks deal to buy eyecare brands from Novartis

JB Chemicals & Pharmaceuticals Ltd, the Mumbai-based drugmaker majority-owned by private equity firm KKR, has acquired a portfolio of ophthalmology ......

Premium
Somerset bets on CDMO firm in fifth deal from second fund

Healthcare

20 April, 2023

Somerset bets on CDMO firm in fifth deal from second fund

Somerset Indus Capital Partners, a healthcare-focused private equity firm, has closed its fifth investment from its second fund with a ......

Aurobindo Pharma's $1-bn deal with Novartis unit Sandoz collapses

Healthcare

02 April, 2020

Aurobindo Pharma's $1-bn deal with Novartis unit Sandoz collapses

Aurobindo Pharma Ltd’s planned acquisition of the US generic oral solids and dermatology businesses of Sandoz Inc., a unit of ......

Grapevine: RIL in talks with banks for Alok Industries; Temasek may invest in Licious

General

09 December, 2019

Grapevine: RIL in talks with banks for Alok Industries; Temasek may invest in Licious

Reliance Industries Ltd (RIL) is in negotiations with State Bank of India (SBI), HDFC Bank and ICICI Bank to fund ......

Sequoia India-backed Biofourmis buys Swiss firm Biovotion

TMT

19 November, 2019

Sequoia India-backed Biofourmis buys Swiss firm Biovotion

Biofourmis Singapore Pte. Ltd, a digital therapeutics firm, said on Tuesday it has acquired Switzerland-based wearable biosensor platform Biovotion AG. Biofourmis ......

Aurobindo buying Novartis unit Sandoz's businesses in biggest outbound pharma deal

Healthcare

06 September, 2018

Aurobindo buying Novartis unit Sandoz's businesses in biggest outbound pharma deal

Aurobindo Pharma Ltd has agreed to purchase Novartis AG unit Sandoz Inc.’s US dermatology and generic pills business for as ......

Sun Pharma to acquire cancer drug from Novartis for $175 mn

Healthcare

22 December, 2016

Sun Pharma to acquire cancer drug from Novartis for $175 mn

Sun Pharmaceutical Industries Ltd, India’s biggest drugmaker, plans to acquire skin cancer drug Odomzo from Swiss firm Novartis AG for ......